Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial von Paton, Nicholas I, Gurumurthy, Meera, Lu, Qingshu, Leek, Francesca, Kwan, Philip, Koh, Hiromi W L, Molton, James, Mortera, Lalaine, Naval, Sullian, Bakar, Zamzurina Abu, Pang, Yong-Kek, Lum, Lionel, Lim, Tow Keang, Cross, Gail B, Lekurwale, Ganesh, Choi, Hyungwon, Au, Veonice, Connolly, John, Hibberd, Martin, Green, Justin A

Volltext

Point‐of‐care activated system versus conventional intravenous admixture system at an academic medical centre in Singapore von Woon, Chin Menn, Tan, Thor Eng, Hooi, Pik Yee, Teoh, Siang Nee, Wu, Tuck Seng

Volltext